FRESH TRACKS THERAPEUTICS, INC.

Analyst Reco. Fresh Tracks Therapeutics, Inc.

Equities

FRTX

US10802T2042

Market Closed - OTC Markets Other stock markets 12:01:36 2024-05-17 pm EDT			5-day change	1st Jan Change
0.9335 ^USD	0.00%		+2.44%	+6.19%

Mar. 15	Fresh Tracks Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
2023	Fresh Tracks Therapeutics, Inc.(OTCPK:FRTX) dropped from S&P TMI Index	CI

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Wall Street Set to Open Wednesday Trading Higher as Investors Await Fed Decision on Interest Rates	23-09-20	MT
US Futures Rise Modestly Pre-Bell as Investors Await Fed Rate Decision	23-09-20	MT
Oppenheimer Adjusts Fresh Tracks Therapeutics Price Target to $4 From $9, Maintains Outperform Rating	22-11-14	MT
Oppenheimer Adjusts Price Target on Fresh Tracks Therapeutics to $9 From $1, Maintains Outperform Rating	22-09-27	MT
HC Wainwright Adjusts Brickell Biotech's Price Target to $4.50 From $2, Keeps Buy Rating	22-08-16	MT
Lake Street Downgrades Brickell Biotech to Hold From Buy, Lowers Price Target to $0.25 From $2	22-05-13	MT
Oppenheimer Adjusts Brickell Biotech's Price Target to $1 From $4, Maintains Outperform Rating	22-05-13	MT
Wall Street Set for Higher Open Ahead of Fed Funds Rate Announcement, ISM's Services Index	22-05-04	MT
William Blair Initiates Coverage on Brickell Biotech With Outperform Rating	22-03-08	MT
HC Wainwright Starts Brickell Biotech at Buy With $2 Price Target	22-01-18	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.

BENEFIT NOW